Impact of Registry Implementation on the Management and Survival of Patients with Pulmonary Embolism

Pulmonary embolism (PE) is a major public health concern, with a considerable mortality rate. In the present study, we have evaluated the impact of registry implementation on PE management.

In the present single-center study, composed of two distinct cohorts, we have evaluated the impact of registry implementation (prospective arm-September 2015 to August 2018) on patient management and survival, and compared it with the same duration when no registry was implied (retrospective arm-September 2012 to August 2015).

One hundred and seventy and 182 patients were recruited in the prospective and retrospective arms, respectively. Guideline‑recommended risk stratification was significantly overlooked before the introduction of PE registry (100% vs. 45.6% prospective and retrospective arms, respectively [P < 0.001]). Atrend toward higher administration of thrombolytic therapy was noted in patients admitted during the registry time (20 [64.5%] vs. 3 [37.5%], P = 0.166). The registry had also significant impact on length of hospital stay (6.72 ± 4.39 days versus 9.35 ± 5.55, P = 0.001, in prospective and retrospective arms, respectively). No significant difference was detected on the 6‑month all‑cause mortality. However, re‑venous thromboembolism was significantly reduced during registry time (2 [1.2%) vs. 22 [12.2%], P < 0.001). Finally, significantly more patients underwent guideline‑recommended follow‑up during the registry time (107 [72.3%] vs. 30 [16.5%], P < 0.001).

Our study showed the implementation of registry had significant effect on PE‑related outcome and might have direct impact on burden of pulmonary emboli on the healthcare system.